Law & Medicine

Complementary and alternative medicine


 

Dr. Tan is emeritus professor of medicine and former adjunct professor of law at the University of Hawaii, Honolulu. This article is modified from a chapter in the author’s book, “Medical Malpractice: Understanding the Law, Managing the Risk.” It is meant to be educational and does not constitute medical, ethical, or legal advice. For additional information, readers may contact the author at siang@hawaii.edu.

References

1. Wengel v. Herfert, 473 N.W.2d 741 (1991).

2. Salazar v. Ehmann, 505 P.2d 387 (1972).

3. Miyamoto v. Lum and Lazo, 84 P.3d 509 (2004).

4. Rosenberg v. Jing Jiang, 153 A.D.3d 744 (2017).

5. Wallman v. Kelley, 976 P.2d 330 (1998).

6. Charell v. Gonzales, 673 N.Y.S. 2d 685 (1998).

7. Gonzales v. NYS DOH, 232 A.D.2d 886 (1996).

8. Schneider v. Revici, 817 F. 2d 987 (1987).

Pages

Recommended Reading

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale
MDedge Dermatology
Terminating an employee
MDedge Dermatology
Miscommunication With Dermatology Patients: Are We Speaking the Same Language?
MDedge Dermatology
Conservatism spreads in prostate cancer
MDedge Dermatology
Survey: Health care costs, access unlikely to improve in 2019
MDedge Dermatology
Fund projects, not people to address gender bias in research funding
MDedge Dermatology
ONC aims to help docs, patients with information sharing in proposed rule
MDedge Dermatology
Culture change needed to improve gender inequalities in medicine
MDedge Dermatology
A prescription for medicine’s gender inequality
MDedge Dermatology
McAneny: Transparency needed for meaningful talk on drug pricing
MDedge Dermatology